BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9668628)

  • 1. Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys, and humans.
    Sarnyai Z
    Ann N Y Acad Sci; 1998 Jun; 851():371-87. PubMed ID: 9668628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats.
    Sarnyai Z; Bíró E; Gardi J; Vecsernyés M; Julesz J; Telegdy G
    Brain Res; 1995 Mar; 675(1-2):89-97. PubMed ID: 7796157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cocaine and corticotropin-releasing factor on pulsatile ACTH and cortisol release in ovariectomized rhesus monkeys.
    Sarnyai Z; Mello NK; Mendelson JH; Nguyen PH; Erös-Sarnyai M
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2745-51. PubMed ID: 7673418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal.
    Kupferschmidt DA; Newman AE; Boonstra R; Erb S
    Neuroscience; 2012 Mar; 204():125-33. PubMed ID: 21784132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats.
    Sarnyai Z; Bíró E; Penke B; Telegdy G
    Brain Res; 1992 Aug; 589(1):154-6. PubMed ID: 1330207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal.
    Skelton KH; Gutman DA; Thrivikraman KV; Nemeroff CB; Owens MJ
    Psychopharmacology (Berl); 2007 Jun; 192(3):385-96. PubMed ID: 17297634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.
    Flandreau EI; Ressler KJ; Owens MJ; Nemeroff CB
    Psychoneuroendocrinology; 2012 Jan; 37(1):27-38. PubMed ID: 21616602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats.
    Zorrilla EP; Valdez GR; Weiss F
    Psychopharmacology (Berl); 2001 Dec; 158(4):374-81. PubMed ID: 11797058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of corticotropin-releasing factor in drug addiction.
    Sarnyai Z; Shaham Y; Heinrichs SC
    Pharmacol Rev; 2001 Jun; 53(2):209-43. PubMed ID: 11356984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus-pituitary-adrenal axis reactivity in mice with mild traumatic brain injury.
    Kosari-Nasab M; Sadeghi T; Bashiri H; Shokouhi G; Salari AA
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):220-228. PubMed ID: 30883392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders.
    Owens MJ; Vargas MA; Nemeroff CB
    J Psychiatr Res; 1993; 27 Suppl 1():209-20. PubMed ID: 8145178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats.
    Sarnyai Z; Höhn J; Szabó G; Penke B
    Life Sci; 1992; 51(26):2019-24. PubMed ID: 1335535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.
    Koob GF; Heinrichs SC
    Brain Res; 1999 Nov; 848(1-2):141-52. PubMed ID: 10612706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats.
    Sarnyai Z; Bíró E; Gardi J; Vecsernyés M; Julesz J; Telegdy G
    Brain Res; 1993 Jul; 616(1-2):315-9. PubMed ID: 8358623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential neuroendocrine and behavioral responses to cocaine in Lewis and Fischer rats.
    Simar MR; Saphier D; Goeders NE
    Neuroendocrinology; 1996 Jan; 63(1):93-100. PubMed ID: 8839360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.